Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
- 1 December 2009
- journal article
- Published by Elsevier in Journal of Nutrition
- Vol. 139 (12) , 2393-2396
- https://doi.org/10.3945/jn.109.113332
Abstract
The reversible acetylation of histones is an important mechanism of gene regulation. During prostate cancer progression, specific modifications in acKeywords
This publication has 30 references indexed in Scilit:
- Niacin Status Impacts Chromatin Structure 1–3Journal of Nutrition, 2009
- Overview to Symposium “Nutrients and Epigenetic Regulation of Gene Expression” ,Journal of Nutrition, 2009
- One-Carbon Metabolism–Genome Interactions in Folate-Associated Pathologies ,Journal of Nutrition, 2009
- Repression of Transposable Elements by Histone Biotinylation ,Journal of Nutrition, 2009
- Dietary histone deacetylase inhibitors: From cells to mice to manPublished by Elsevier ,2007
- Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis inApcminmiceThe FASEB Journal, 2006
- Upregulation and Nuclear Recruitment of HDAC1 in Hormone Refractory Prostate CancerThe Prostate, 2004
- Nuclear Accumulation of Histone Deacetylase 4 (HDAC4) Coincides with the Loss of Androgen Sensitivity in Hormone Refractory Cancer of the ProstateEuropean Urology, 2003
- Histone Deacetylase and DNA Methyltransferase in Human Prostate CancerBiochemical and Biophysical Research Communications, 2001
- Histone Hyperacetylation Induced by Histone Deacetylase Inhibitors Is Not Sufficient to Cause Growth Inhibition in Human Dermal FibroblastsJournal of Biological Chemistry, 2001